Matinas BioPharma Inc.
MTNB | AMEX
$1.51
-$0.39 (-20.53%)
At close: Oct 30, 2026, 3:59 PM ET
$1.19
-$0.32 (-21.19%)
Pre-market:
Nov 2, 2026, 6:02 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -1.33M | -1.92M | -1.91M | -1.53M | -5.25M | -1.66M | -8.43M | -4.28M | -5.72M | -5.82M | -5.31M | -6.06M | -6.06M | -5.51M | -3.63M | -5.46M | -5.92M | -5.98M | -6.7M | -6.84M | -4.79M | -4.96M |
Depreciation & Amortization | -74K | 74K | 423K | 331K | -98K | 128K | 247K | 240K | 241K | 240K | 240K | 238K | 234K | 229K | 225.82K | 230K | 231K | 211.53K | 205.11K | 196.04K | 182.79K | 197.56K |
Stock-Based Compensation | 104K | n/a | 217K | 253K | 238K | 315K | 244K | 965K | 991K | 995K | 1.27M | 1.2M | 1.21M | 1.27M | n/a | 1.41M | 1.22M | n/a | 1.07M | 1.06M | 1.06M | 1.1M |
Other Working Capital | -123K | -264K | -458K | -220K | -365K | -687K | 340K | -548K | 1.65M | -1.16M | -475K | -45K | 2.31M | -17K | -2.25M | -1.36M | 152K | -1.01M | 1.11M | -1.65M | 2.6M | -1.12M |
Other Non-Cash Items | -549K | 113K | -14K | -220K | 3.57M | -294K | 4.35M | 7K | -37K | 18K | 18K | 17K | 29K | 44K | 1.4M | 48K | 49K | 1.61M | 80.43K | 1.26M | 54.31K | 54.25K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 9K | 133K | -223K | -306K | -481K | -500K | 86K | -437K | 1.42M | -1.2M | -795K | 185K | 2.4M | -119K | -2.29M | -1.2M | -703K | -600.99K | 1.38M | -1.43M | 2.63M | -1.05M |
Operating Cash Flow | -1.84M | -1.6M | -1.51M | -1.47M | -2.02M | -2.01M | -3.51M | -3.5M | -3.11M | -5.77M | -4.58M | -4.42M | -2.19M | -4.09M | -4.3M | -4.97M | -5.13M | -4.76M | -3.96M | -5.75M | -864.66K | -4.65M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16K | -202K | n/a | -41.6K | -250K | -55K | -544.56K | -36.19K | -224.19K | -5 | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8.44M | n/a | n/a | n/a | n/a | n/a | n/a | -412 | n/a | -6.99M | -2.49M | -5.41M | -10.66M | -3.05M | -4.08M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | 500K | 10.15M | 5M | 2M | 2.96M | 1.1M | 6.4M | 3M | n/a | 6M | 3.25M | 6M | 5.5M | 11.13M | 10.7M | 12.9M |
Other Investing Acitivies | n/a | n/a | 15K | 320K | n/a | n/a | n/a | 7.94M | -7.94M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | 15K | 320K | n/a | n/a | 500K | 9.65M | -2.94M | 2M | 2.96M | 1.08M | 6.2M | 3M | -42.01K | 5.75M | -3.79M | 2.96M | 56.67K | 242.7K | 7.65M | 8.82M |
Debt Repayment | -1K | n/a | -7K | n/a | -1K | -1K | -1K | -2K | -1K | -1K | -1K | -1K | -1K | -4K | -4.2K | -3K | -6K | -6.53K | -6.39K | -8.32K | -8.15K | -7.98K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | -27K | -2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1 | n/a | 1.21M |
Financial Cash Flow | -1K | n/a | 58K | 64K | 1.62M | 1.65M | -1K | -67K | 9.19M | 53K | -1K | -1K | -1K | -4K | -4.64K | -3K | -6K | 92.92K | 8.09K | -8.32K | 180.48K | 6.78M |
Net Cash Flow | -1.84M | -1.6M | -1.44M | -1.09M | -399K | -360K | -3.01M | 6.08M | 3.15M | -3.72M | -1.62M | -3.34M | 4M | -1.09M | -4.35M | 777K | -8.93M | -1.7M | -3.89M | -5.52M | 6.97M | 10.95M |
Free Cash Flow | -1.84M | -1.6M | -1.51M | -1.47M | -2.02M | -2.01M | -3.51M | -3.5M | -3.11M | -5.77M | -4.58M | -4.44M | -2.4M | -4.09M | -4.34M | -5.22M | -5.19M | -5.3M | -3.99M | -5.97M | -864.66K | -4.65M |
Adj. Free Cash Flow | -1.94M | -1.6M | -1.73M | -1.73M | -2.26M | -2.32M | -3.75M | -4.47M | -4.1M | -6.76M | -5.85M | -5.63M | -3.6M | -5.36M | -4.34M | -6.63M | -6.4M | -5.3M | -5.07M | -7.03M | -1.92M | -5.75M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16K | -202K | n/a | n/a | n/a | n/a | -544.56K | -36.19K | -224.19K | -5 | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -41.6K | -250K | -55K | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -1.84M | -1.6M | -1.51M | -1.47M | -2.02M | -2.01M | -3.51M | -3.5M | -3.11M | -5.77M | -4.58M | -4.44M | -2.4M | -4.09M | -4.3M | -4.97M | -5.13M | -5.3M | -3.99M | -5.97M | -864.66K | -4.65M |
Add to Watchlist
Select watchlists to add or remove MTNB